Status:

COMPLETED

Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborating Sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Toronto General Hospital

Conditions:

Liver Failure

Liver Diseases

Eligibility:

All Genders

Brief Summary

The overarching objective of the research program entitled ELIPTO (Enhancing Liver Insufficiency and Postoperative Transplantation Outcomes) (www.elipto.ca) is to improve the perioperative care of liv...

Detailed Description

OBJECTIVES: The main objective of this study is to describe and measure the effects of intraoperative hemodynamic management on postoperative outcomes in liver transplantation in Canada and France. ...

Eligibility Criteria

Inclusion

  • All consecutive adult liver transplant recipients in each center during a one-year period or more (anywhere in between June 1, 2021 and November 30, 2022).

Exclusion

  • Same patients who undergo a retransplantation during the same period of observation.

Key Trial Info

Start Date :

January 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 30 2023

Estimated Enrollment :

852 Patients enrolled

Trial Details

Trial ID

NCT04732689

Start Date

January 1 2021

End Date

November 30 2023

Last Update

February 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de l'Université de Montréal (CHUM)

Montreal, Quebec, Canada, H2X 3E4

Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation | DecenTrialz